跳至主要内容
临床试验/CTRI/2023/04/051566
CTRI/2023/04/051566进行中(未招募)不适用

Effect of an oral nutrition supplement on growth in Indian children in age group 3-6.9 years at nutritional risk: A prospective, randomized, open label, controlled, parallel study.

Abbott Healthcare Pvt Ltd1 个研究点 分布在 1 个国家目标入组 234 人开始时间: 2023年6月23日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
234
试验地点
1
主要终点
1.Change in height-for-age WHO percentile

研究概览

简要总结

The study is being conducted to evaluate the effect of an oral nutrition supplement on growth in Indian children in age group 3-6.9 years at nutritional risk. The study will investigate the effect of oral nutritional supplement (ONS) along with dietary counselling vs only dietary counselling on anthropometric growth parameters among preschool children from India, aged ≥ 3 to 6.9 years.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
3.00 Year(s) 至 6.90 Year(s)(—)
性别
All

入选标准

  • A subject will be considered eligible for inclusion in this study only if ALL of the following criteria apply:
  • Subject (male or female) aged 3.0-6.9 years, and residing in India
  • Subject to remain in the same locality for the duration of the study (up to 6 months)
  • Subject has a Height for age less than 25th percentile according to current WHO Growth Charts (WHO Growth Chart 2007)
  • Subject has a weight for height less than 25th percentile according to current WHO Growth Charts (WHO Growth Chart 2007)
  • Subject is able to consume foods and beverages orally
  • Child is a picky eater, defined as meeting at least two of the following criteria.
  • A child, who a.
  • eats only a limited number of foods b.is unwilling to try new foods c.
  • refuses to eat vegetables and or foods from other food groups d.
  • shows strong food likes and dislikes 16 e.
  • has behaviors that disrupt mealtime
  • Child is a habitual milk drinker at least 1 glass (approx.
  • 200ml) of milk daily.
  • Subject with good general and mental health in the investigator’s opinion
  • Subject’s parent or LAR understand and are willing, able and likely to comply with all study procedures and restrictions
  • Subject’s parent or LAR are willing to sign the ICF.

排除标准

  • Subject’s meeting any of the following criteria are not eligible for the study:
  • Subject has been diagnosed with Lactose Intolerance & Galactosemia according to medical records or parent or LAR report.
  • Subject has been diagnosed or is known to be allergic or intolerant to any ingredient found in the study product according to medical records or parent or LAR report.
  • Subject has been diagnosed with a developmental disability, including pathological reason for stunted & wasting, physical disorders such as cerebral palsy, or developmental delay according to medical records or parent or LAR report.
  • Subject with recent history (within 3 months prior to signing ICF) of surgery, serious infections or injuries
  • Subject who is immunocompromised (e.g. HIV infection, AIDS, congenital immunodeficiency) or has known congenital diseases or malformations (e.g. gastrointestinal malformations) or has a history of endocrine abnormality or has chronic illnesses or conditions (e.g. jaundice, asthma, diabetes, cancer, tuberculosis, diarrhea, etc) or medications (e.g. systemic corticosteroids) which could interfere with the study objectives
  • Subject who needs to be fed with a special diet OR who needs to be fed with a diet which is different from that advised by the study center nutritionist OR current taking a nutritional supplement (MVM with average consumption of greater than or equal to 10 percent) in the past 3 months prior to screening
  • Subject on restrictions that prevent adherence to the diet plan, which is advised by the study center nutritionist during dietary advice 17
  • Subject with known food allergies as reported by parent or LAR
  • Subject currently participating, or has participated in a drug or device study or a nutritional program run by the local government or NGO within a period of 30 days prior to screening.

结局指标

主要结局

1.Change in height-for-age WHO percentile

时间窗: at 6 months compared to baseline

次要结局

  • 1.Change in height-for-age WHO percentile(2.Change in height-for-age WHO z-score)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验